Valsartan in the Treatment of Hypertension
Salem Alajbegovic, Aziz Sukalo, Azra Alajbegovic, Jasminka Djelilovic Vranic, Melika Ambeskovic, Dervis Deljo, Lejla Alajbegovic.
|Cited by (1)|
Introduction: Hypertension represents an important public health problem. Effective treatment of hypertension is imperative for primary care. Goal: The goal of this study was to examine the efficacy of Valsartan in the treatment of hypertension with emphasis on the overall efficacy in reduction of systolic and diastolic blood pressure in a sample of 738 patients. Material and methods: The study lasted for 12 months (from January 1, 2012 until December 31, 2012 year) and conducted in 18 public health institutions in B&H. Parallel follow up of Valsartan antihypertensive effect through repeated measurements every three months was conducted. Results and discussion: Our results indicate that both systolic and diastolic blood pressure decreased significantly after 12 weeks of Valsartan treatment. Analysis of adverse effects did not showed statistical significance of side effects for total sample. Statistical analysis by Yates chi-square did not show the presence of statistically significant differences in adverse effects by gender. Conclusion: We conclude that Val or Val plus are effective and safe antihypertensive drugs for the treatment of mild to moderate hypertension.
Archives of Clinical and Experimental Surgery (ACES)
SUBMIT YOUR ARTICLE NOW